Back to Search Start Over

Squamous cell carcinoma of the lower lip: FAS/FASL expression, lymphocyte subtypes and outcome.

Authors :
Somma P
Lo Muzio L
Mansueto G
Delfino M
Fabbrocini G
Mascolo M
Mignogna C
Di Benedetto M
Carinci F
De Lillo A
Pastore L
Serpico R
De Rosa G
Staibano S
Source :
International journal of immunopathology and pharmacology [Int J Immunopathol Pharmacol] 2005 Jan-Mar; Vol. 18 (1), pp. 59-64.
Publication Year :
2005

Abstract

Squamous cell carcinoma (SCC) of the lip is a relatively common malignancy of the head and neck region. Tumour thickness, grading and perineural invasion are significant prognostic indicators. However, there is still the need of new reliable biological markers able to predict the prognosis of the single cases with an unfavourable biological behaviour unpredictable by the classic clinical-pathological parameters. 32 cases of (SCC) of the lower lip were analysed for their clincopathologic features, and immunohistochemical expression of Fas/FasL in neoplastic cells and in inflammatory infiltrate. Moreover the density and phenotype of tumour-infiltrating lymphocytes (TIL) were analysed. The results were related with the follow-up of the patients ranging from 2 to 6 years. The cases with over-expression of Fas/FasL in neoplastic cells and Fas+ in T cells preferentially showed a more aggressive clinical behaviour (P<0.01). Moreover we found an alteration of the normal expression of CD4 and CD8 lymphocyte types in ten cases. This data suggest that the Fas/FasL pathway is involved in the close relation between neoplastic cells and T cells and so in the biological behaviour of these tumours.

Details

Language :
English
ISSN :
0394-6320
Volume :
18
Issue :
1
Database :
MEDLINE
Journal :
International journal of immunopathology and pharmacology
Publication Type :
Academic Journal
Accession number :
15698511
Full Text :
https://doi.org/10.1177/039463200501800107